Standard radiation for medulloblastoma can cause long-term damage to a child's developing brain. A new clinical trial suggests that the volume and dose of radiation could be safely tailored based on genetic features in the patient's tumor.
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892
No comments:
Post a Comment